Green Tea Lozenges for the Management of Dry Mouth

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE1/PHASE2

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-03-31

Study Completion Date

2013-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this proposal is to investigate the effectiveness of a Medical College of Georgia patent pending formulation of natural plant extracts on patients with xerostomia. The major component of this formulation is green tea extract with a defined composition of polyphenols. Epidemiological studies suggest that phytochemicals in green tea possess beneficial effects on autoimmune and inflammatory diseases. Thus far, there is little evidence to indicate any marked and direct immunomodulatory effect of green tea on T or B lymphocytes. However, there is considerable evidence for green tea polyphenols (GTPs), major phytochemicals found in green tea extract, having properties consistent with effects on cells of tissues that would be protective towards local inflammation.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Beneficial Effects of Natural Products on Management of Xerostomia

NCT06217614

Xerostomia Diabetes Mellitus Hypertension +1 more

COMPLETED NA

CLINICAL EVALUATION OF THE EFFICACY OF AN INTRA ORAL SPRAY FOR PATIENTS WITH XEROSTOMIA

NCT04719091

Dry Mouth, Xerostomia.Hyaluronic Acid, Xylitol

COMPLETED NA

Exploratory Study in the Relief of Drug-induced Xerostomia Associated With Hyposialia

NCT02005328

Drug-induced Xerostomia

COMPLETED NA

Effect of Saliva Substitutes on Dental Hard Tissues in Situ

NCT01165970

Hyposalivation

TERMINATED PHASE2/PHASE3

Treatment of Xerostomia by Herbal Preparation

NCT01579877

Xerostomia

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients with subjective complaints of xerostomia will be given a screening questionnaire to complete. If they meet the criteria on this screening form, the research coordinator will be notified and will meet with the patient either immediately or at a scheduled follow-up appointment. The research coordinator will review the information and then explain the details of the study to the patient and obtain informed consent. Once the patient has signed the informed consent, the research coordinator will collect the demographic, medical history, and contact information from the patient. Any information missing will be noted for follow-up investigation by the research coordinator. If a subject is of child bearing age, they will be asked to complete a urine pregnancy test prior to enrollment.\[a\] First appointment -Screening, consent. \[b\]Follow appointments- review, then Patients will do VAS questionnaire, QOL questionnaire, Sialometry will be done measuring unstimulated whole saliva and Stimulated whole saliva for 5 min each.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Xerostomia Sjogren Syndrome Dry Mouth

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

MighTeaFlow

4-6 times daily lozenge containing green tea, jaborandi extracts, and 500 mg xylitol for 8 weeks

Group Type ACTIVE_COMPARATOR

MighTeaFlow

Intervention Type DIETARY_SUPPLEMENT

4-6 times daily

Xylitol

4-6 times daily lozenge containing jaborandi extract, and 500 mg xylitol for 8 weeks

Group Type ACTIVE_COMPARATOR

Xylitol

Intervention Type DIETARY_SUPPLEMENT

4-6 times daily

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

MighTeaFlow

4-6 times daily

Intervention Type DIETARY_SUPPLEMENT

Xylitol

4-6 times daily

Intervention Type DIETARY_SUPPLEMENT

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Green Tea Lozenge Aspartame

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. A complaint of dry mouth as assessed by a response of 30mm or greater on a Dry Mouth Visual Analog Scale (VAS)
2. Clinical Diagnosis of primary or secondary Sjogren's syndrome.
3. Over the age of 18.
4. Taking less than three drugs associated with causing xerostomia or salivary gland hypofunction.
5. Willing to use natural novel topical dry mouth products.
6. Prior minor salivary gland biopsy and serology from Sjogren's Syndrome/Xerostomia work-up.
7. Willing to return for all study-associated visits.
8. Able to read, understand, and sign the informed consent.

Exclusion Criteria

1. Have received radiation to the head and neck region.
2. Unable to read and understand the consent form.
3. On greater than three drugs associated with xerostomia or salivary gland hypofunction.
4. Require dento-alveolar surgery or extensive dental treatment during the course of the study.
5. Require hospitalization for any medical problem during the course of the study.
6. Unable to take green tea leaf extract and/or pilocarpus jaborandi leaf extract and/or xylitol because of allergy
7. Uncontrolled medical conditions that require changes in medication during the course of the study.
8. Regularly consume green tea and/or components of pilocarpus jaborandi.
9. Are pregnant

Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No